{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:23:48Z","timestamp":1785421428345,"version":"3.56.0"},"reference-count":49,"publisher":"American Society for Microbiology","issue":"10","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2025,10,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales complicate clinical management, as they are resistant to standard antibiotics and often necessitate intricate treatment plans. As a result, continuous monitoring is essential to prevent the spread of resistant strains and ensure effective treatment options are available. Enterobacterales are humans\u2019 primary contributors to urinary tract infections (UTIs). Among these,\n                      <jats:italic toggle=\"yes\">Escherichia coli<\/jats:italic>\n                      (\n                      <jats:italic toggle=\"yes\">E. coli<\/jats:italic>\n                      ) sequence type 131 (ST131), which carries \u03b2-lactamase genes with significant virulence potential, has been documented globally.\n                      <jats:italic toggle=\"yes\">E. coli<\/jats:italic>\n                      ST131 mostly belongs to the serotypes O25 and O16 and is a well-defined subclone of the FimH30 and FimH30-Rx. We aimed to evaluate the impact of the ST131 clone carrying three \u03b2-lactamase genes\u2014the\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>CTX-M-1<\/jats:sub>\n                      ,\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>CTX-M-14<\/jats:sub>\n                      , and\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>CTX-M-15<\/jats:sub>\n                      genes\u2014in the antibiotic resistance pattern of ESBL-producing\n                      <jats:italic toggle=\"yes\">E. coli<\/jats:italic>\n                      (ESBL-EC) from UTIs in Guilan, Iran. The phenotypic confirmatory disc diffusion test (PCDDT), according to CLSI recommendations, was utilized to detect ESBL production. The ESBL-EC isolates were screened for the ST131 clone using specific PCR of O25b, O16, H30, and H30-Rx. Out of the 107 ESBL-EC, 70 (65.4%) showed as ST131. Among the ST131 clones, the highest frequency belonged to the ST131-H30 (98.6%). Among the beta-lactam antibiotics, both the ST131 and non-ST131 groups exhibited complete resistance (100%) to cefotaxime, ampicillin, amoxicillin-clavulanate, cephalothin, cefixime, and ceftriaxone while demonstrating the greatest susceptibility to imipenem (\n                      <jats:italic toggle=\"yes\">R<\/jats:italic>\n                      = 0%). In the case of non-beta-lactam antibiotics, both groups showed significant resistance (approximately 91%) to nalidixic acid, while displaying the highest susceptibility to nitrofurantoin (up to 83%). Our study confirmed the dominance of the ST131 clone among the ESBL-EC and \u03b2-lactamase genes associated with the transmission of this pandemic clone.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>IMPORTANCE<\/jats:title>\n                    <jats:p>\n                      Various antibiotic resistance and virulence genes highlight challenges in clinical management and emphasize the need for effective treatment strategies to reduce the risks associated with UTIs. Continuous research is essential to improve knowledge and create innovative approaches to tackle these urological conditions. Our study confirmed the predominance of genes related to the ST131 clone, including O25, O16, H30, and H30-Rx, among ESBL-EC. We found that the\n                      <jats:italic toggle=\"yes\">E. coli<\/jats:italic>\n                      ST131 clone carried\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>CTX-M-1<\/jats:sub>\n                      ,\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>CTX-M-14<\/jats:sub>\n                      , and\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>CTX-M-15<\/jats:sub>\n                      and was expanded in our locale. The clones differed significantly in resistance, susceptibility, and relative susceptibility, only in antibiotic resistance in the case of nitrofurantoin (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Combining resistance genes in the ST131 clone can facilitate its rapid and successful global spread.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/spectrum.02270-24","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T13:29:07Z","timestamp":1755610147000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["Emergence of\n                    <i>Escherichia coli<\/i>\n                    sequence type 131 clone carrying\n                    <i>bla<\/i>\n                    <sub>CTX-M<\/sub>\n                    genes in Guilan Province, Northern Iran"],"prefix":"10.1128","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0663-8764","authenticated-orcid":false,"given":"Samaneh","family":"Kazemi","sequence":"first","affiliation":[{"name":"Department of Microbiology, NT. C., Islamic Azad University","place":["Tehran, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5385-9367","authenticated-orcid":false,"given":"Ali","family":"Mojtahedi","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03w04rv71","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Microbiology, School of Medicine, Iran University of Medical Sciences","place":["Tehran, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9344-1507","authenticated-orcid":false,"given":"Farzaneh","family":"Hosseini","sequence":"additional","affiliation":[{"name":"Department of Microbiology, NT. C., Islamic Azad University","place":["Tehran, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.ARBA-0026-2017"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01376-12"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-49467-5"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-0324-0"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-85116-6"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01555-13"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx089"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01604-13"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00377-13"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00306-11"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02824-14"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2013.06.017"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt519"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv114"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.000012"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-017-0274-0"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1089\/fpd.2012.1267"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01859"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2007.01867.x"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq415"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks278"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2011.05.003"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.06025-11"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx146"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1067\/mda.2003.7"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2296-x"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3405-1"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2012.00009"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10030488"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00125-13"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-14177-y"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-022-00526-2"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.4103\/0976-9668.160014"},{"key":"e_1_3_4_35_2","volume-title":"CLSI supplement M100Performance standards for antimicrobial sensitivity testing","author":"CLSI","year":"2020","unstructured":"CLSI. 2020. CLSI supplement M100. Performance standards for antimicrobial sensitivity testing. 30th ed. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"30"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.12.3724-3732.2003"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2021.07.028"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01412-06"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp194"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.03502-13"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit503"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S212658"},{"key":"e_1_3_4_43_2","first-page":"134","article-title":"Prevalence and molecular characterization of Escherichia coli st131 isolates from patients at a tertiary-care hospital in Phayao province, Thailand (MARCH 2015-JUNE 2017)","volume":"52","author":"Srimora R","year":"2021","unstructured":"Srimora R, Srisong S, Yotthanoo S, Kittiwan N, Poonchareon K. 2021. Prevalence and molecular characterization of Escherichia coli st131 isolates from patients at a tertiary-care hospital in Phayao province, Thailand (MARCH 2015-JUNE 2017). Southeast Asian J Trop Med Public Health 52:134\u2013160.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00125"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S325669"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2019.02.017"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-017-3021-9"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2020.01.024"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01703-10"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.3390\/life14010106"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.02270-24","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.02270-24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T21:30:14Z","timestamp":1759872614000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.02270-24"}},"subtitle":[],"editor":[{"given":"Maria Antonia","family":"De Francesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,7]]}},"alternative-id":["10.1128\/spectrum.02270-24"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.02270-24","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"2024-09-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e02270-24"}}